Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |